Ho TY - Search Results

1

Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds.

Lin CW, Tsai FJ, Tsai CH, Lai CC, Wan L, Ho TY, Hsieh CC, Chao PD. Lin CW, et al. Among authors: ho ty. Antiviral Res. 2005 Oct;68(1):36-42. doi: 10.1016/j.antiviral.2005.07.002. Antiviral Res. 2005. PMID: 16115693 Free PMC article.

2

An in vitro system combined with an in-house quantitation assay for screening hepatitis C virus inhibitors.

Ho TY, Wu SL, Lai IL, Cheng KS, Kao ST, Hsiang CY. Ho TY, et al. Antiviral Res. 2003 May;58(3):199-208. doi: 10.1016/s0166-3542(03)00004-4. Antiviral Res. 2003. PMID: 12767467

3

Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.

Ho TY, Wu SL, Chen JC, Wei YC, Cheng SE, Chang YH, Liu HJ, Hsiang CY. Ho TY, et al. Antiviral Res. 2006 Feb;69(2):70-6. doi: 10.1016/j.antiviral.2005.10.005. Epub 2005 Nov 28. Antiviral Res. 2006. PMID: 16337697 Free PMC article.

4

Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction.

Ho TY, Wu SL, Chen JC, Li CC, Hsiang CY. Ho TY, et al. Antiviral Res. 2007 May;74(2):92-101. doi: 10.1016/j.antiviral.2006.04.014. Epub 2006 May 15. Antiviral Res. 2007. PMID: 16730806 Free PMC article.

5

Novel use of biodegradable casein conduits for guided peripheral nerve regeneration.

Hsiang SW, Tsai CC, Tsai FJ, Ho TY, Yao CH, Chen YS. Hsiang SW, et al. Among authors: ho ty. J R Soc Interface. 2011 Nov 7;8(64):1622-34. doi: 10.1098/rsif.2011.0009. Epub 2011 Apr 27. J R Soc Interface. 2011. PMID: 21525148 Free PMC article.

6

Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.

Ho TY, Wu SL, Cheng SE, Wei YC, Huang SP, Hsiang CY. Ho TY, et al. Biochem Biophys Res Commun. 2004 Jan 23;313(4):938-47. doi: 10.1016/j.bbrc.2003.11.180. Biochem Biophys Res Commun. 2004. PMID: 14706633 Free PMC article.

7

Morin inhibits 12-O-tetradecanoylphorbol-13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression.

Hsiang CY, Wu SL, Ho TY. Hsiang CY, et al. Among authors: ho ty. Biochem Pharmacol. 2005 Jun 1;69(11):1603-11. doi: 10.1016/j.bcp.2005.03.008. Epub 2005 Apr 18. Biochem Pharmacol. 2005. PMID: 15896340

8

Anti-diarrheal effect of Galla Chinensis on the Escherichia coli heat-labile enterotoxin and ganglioside interaction.

Chen JC, Ho TY, Chang YS, Wu SL, Hsiang CY. Chen JC, et al. Among authors: ho ty. J Ethnopharmacol. 2006 Feb 20;103(3):385-91. doi: 10.1016/j.jep.2005.08.036. Epub 2005 Oct 6. J Ethnopharmacol. 2006. PMID: 16213682

9

Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells.

Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY. Lee CH, et al. Among authors: ho ty. Pharmacol Res. 2007 Sep;56(3):193-201. doi: 10.1016/j.phrs.2007.06.003. Epub 2007 Jun 21. Pharmacol Res. 2007. PMID: 17681786

10

Microarray analysis of vanillin-regulated gene expression profile in human hepatocarcinoma cells.

Cheng WY, Hsiang CY, Bau DT, Chen JC, Shen WS, Li CC, Lo HY, Wu SL, Chiang SY, Ho TY. Cheng WY, et al. Among authors: ho ty. Pharmacol Res. 2007 Dec;56(6):474-82. doi: 10.1016/j.phrs.2007.09.009. Epub 2007 Sep 12. Pharmacol Res. 2007. PMID: 17949990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters